Pushing the limits of proteomics: new computational tools for medical research
Description of the granted funding
It is crucial to develop robust versatile computational tools to translate high-throughput proteome data to patient benefits. Mass spectrometry proteomics provides a compelling option for biomarker studies thanks to its capabilities beyond genomic studies. So far, however, this has not fully delivered the promise. To this end, this project develops a robust computational framework to enable incorporation of all available mass spectral information in the modelling, making it is possible to reveal markers not detected by current state-of-the-art tools. In addition to single-species proteomics, the framework is applicable to metaproteomics studies. By combining multidisciplinary expertise in statistical and machine learning, proteomics and clinical research, the project is anticipated to accelerate development of improved diagnosis, prognosis and treatment strategies for complex diseases, such as diabetes. The computational framework will be useful in a wide range of medical applications.
Show moreStarting year
2021
End year
2026
Granted funding
Other information
Funding decision number
341342
Fields of science
Biomedicine
Research fields
Biolääketieteet
Identified topics
bioinformatics